Exchange: NASDAQ·Updated 06:13 PM EDT
News
all
press releases
Do Options Traders Know Something About AstraZeneca Stock We Don't?
Investors need to pay close attention to AZN stock based on the movements in the options market lately.
Zacks
More News
Hedge Funds are Bullish on AstraZeneca PLC (AZN)
Hedge Funds are Bullish on AstraZeneca PLC (AZN...
Yahoo! Finance: News
Hedge Funds are Bullish on AstraZeneca PLC (AZN)
Hedge Funds are Bullish on AstraZeneca PLC (AZN...
Yahoo! Finance: News
MRK Stock Up 5.6% in a Month as Estimates Fall: Buy, Hold or Sell?
Merck's strong Keytruda sales and pipeline progress support its long-term outlook, but falling estimates and patent risks cloud the near term.
Zacks
Ironwood Q2 Earnings Beat Estimates, Revenues Lag, 2026 View Raised
IRWD tops Q2 earnings estimates, misses on revenues and lifts its 2026 outlook as strong Linzess demand drives year-over-year growth.
Zacks
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC- AZN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC- AZN INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC- AZN PR Newswire NEW YORK, Aug. 6, 2026 NEW YORK, Aug. 6, 2026 /PRNewswire/ -- Pomerantz LLP is...
PR Newswire
Moderna's mRNA Flu Vaccine Approved By FDA
Moderna's mRNA Flu Vaccine Approved By FDA Authored by Rachel Roberts via The Epoch Times, The U.S. Food and Drug Administration has approved Moderna's flu shot for over-50s, marking the first time the agency has licensed a messenger ribonucleic acid (mRNA) vaccine for seasonal...
Zero Hedge
Moderna's mRNA Flu Vaccine Approved By FDA
Moderna's mRNA Flu Vaccine Approved By FDA Authored by Rachel Roberts via The Epoch Times, The U.S. Food and Drug Administration has approved Moderna's flu shot for over-50s, marking the first time the agency has licensed a messenger ribonucleic acid (mRNA) vaccine for seasonal...
Zero Hedge
AstraZeneca may buck a decade of pharma strategy to buy U.S. scale
Reports of preliminary talks between AstraZeneca and Bristol Myers Squibb moved shares and reignited debate over Big Pharma consolidation...
CNBC: Top News
AstraZeneca may buck a decade of pharma strategy to buy U.S. scale
Reports of preliminary talks between AstraZeneca and Bristol Myers Squibb moved shares and reignited debate over Big Pharma consolidation...
CNBC: Top News

Advertisement|Remove ads.